Nurandociguat

N/A

Report date: 2026/05/06 20:02:28
NME

Base Information

Drug NameNurandociguat
Drug Alias NamesGC Activator 4 (Bayer)BAY-3283142
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGuanylate cyclase stimulantsSoluble guanylate cyclase stimulants
TargetsGuanylate cyclaseSoluble guanylate cyclase
Therapy Area/IndicationsHypertensionCoronary Artery DiseaseRenal Insufficiency, Chronic +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumBulgariaUnited States +[17] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AGBayer Healthcare Company Ltd
Inactive CompaniesN/A
Active IndicationsHypertensionCoronary Artery DiseaseRenal Insufficiency, Chronic +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A